The survey’s findings are consistent with those of others reporting rising rates of cannabis use among older adults and seniors.
“Passage of this legislation will provide qualified patients with a state-sanctioned option to access a therapy that has proven to offer significant benefits.”
It is time for Gov. Carney to acknowledge and support the majority of Delawareans who back cannabis legalization in the First State.
Recently conducted observational trials in Israel and the United Kingdom have documented improved symptoms following the use of cannabis products among patients with post-traumatic stress. These outcomes include statistically significant changes in sleep quality and in anxiety, fewer nightmares, and improved quality of life.
“These findings contribute robust evidence for clinicians regarding the potential benefits of medical cannabis in reducing the opioid burden for patients receiving long-term opioid therapy and possibly reduc[ing] their risk for overdose.”
By taking cannabis products off street corners and placing them behind the counter, lawmakers can provide consumers with a safer experience and greatly reduce their risk of being inadvertently exposed to contaminated products.
Investigators reported, “Contrary to concerns about spillover effects, implementation of legalized non-medical cannabis coincided with decreases in alcohol and cigarette use and pain reliever misuse.”
Sixty-one percent of respondents said that they “replaced” prescription opioids and/or benzodiazepines with medical cannabis – a finding that is consistent with several other studies.